{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05037487",
            "orgStudyIdInfo": {
                "id": "21-001137"
            },
            "organization": {
                "fullName": "University of California, Los Angeles",
                "class": "OTHER"
            },
            "briefTitle": "Evaluation of Smoked THC and CBD in Men and Women",
            "officialTitle": "Evaluation of Smoked THC and CBD in Oral Fluid, Pharmacokinetics, and Subjective and Neurocognitive Effects in Men and Women",
            "acronym": "S-TACOFS",
            "therapeuticArea": [
                "Other"
            ],
            "study": "evaluation-of-smoked-thc-and-cbd-in-men-and-women"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-09-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-03-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-08-31",
            "studyFirstSubmitQcDate": "2021-08-31",
            "studyFirstPostDateStruct": {
                "date": "2021-09-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Ziva D. Cooper, PhD",
                "investigatorTitle": "Associate Professor",
                "investigatorAffiliation": "University of California, Los Angeles"
            },
            "leadSponsor": {
                "name": "University of California, Los Angeles",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to determine the pharmacokinetics and pharmacodynamics of inhaled cannabis with varying amounts of delta-9-tetrahydrocannabinol (THC), and cannabidiol (CBD) and to evaluate detection of recently smoked THC in oral fluid.",
            "detailedDescription": "This double-blind placebo controlled, within-subject study study will assess testing devices that can measure biochemical markers in oral fluid and neurocognitive-performance markers of recent cannabis use. Other pharmacodynamic effects of inhaled cannabis with CBD and THC will be determined and the pharmacokinetics of THC, CBD, and respective metabolites will be assessed in whole blood."
        },
        "conditionsModule": {
            "conditions": [
                "Drug Abuse",
                "Intoxication by Drug",
                "Impairment"
            ],
            "keywords": [
                "Cannabis",
                "THC",
                "CBD",
                "Intoxication",
                "Impairment"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "interventionModelDescription": "This is a randomized, double-blind, placebo-controlled study. All participants will complete all dose conditions in a randomized order.",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 22,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Smoked placebo cannabis",
                    "interventionNames": [
                        "Drug: Placebo Cannabis"
                    ]
                },
                {
                    "label": "20 mg CBD",
                    "type": "EXPERIMENTAL",
                    "description": "Smoked cannabis with CBD",
                    "interventionNames": [
                        "Drug: 20 mg CBD Cannabis"
                    ]
                },
                {
                    "label": "20 mg CBD + 20 mg THC",
                    "type": "EXPERIMENTAL",
                    "description": "Smoked cannabis with CBD and THC",
                    "interventionNames": [
                        "Drug: 20 mg CBD + 20 mg THC Cannabis"
                    ]
                },
                {
                    "label": "20 mg THC",
                    "type": "EXPERIMENTAL",
                    "description": "Smoked cannabis with THC",
                    "interventionNames": [
                        "Drug: 20 mg THC Cannabis"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Placebo Cannabis",
                    "description": "Smoked placebo cannabis",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "20 mg CBD Cannabis",
                    "description": "Smoked cannabis with CBD",
                    "armGroupLabels": [
                        "20 mg CBD"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "20 mg CBD + 20 mg THC Cannabis",
                    "description": "Smoked cannabis with CBD and THC",
                    "armGroupLabels": [
                        "20 mg CBD + 20 mg THC"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "20 mg THC Cannabis",
                    "description": "Smoked cannabis with THC",
                    "armGroupLabels": [
                        "20 mg THC"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Subjective drug effect ratings of impairment and abuse liability",
                    "description": "Peak subjective ratings of drug effects associated with abuse liability and impairment as measured using visual analogue scales (VAS; 1-100mm).",
                    "timeFrame": "6 hours"
                },
                {
                    "measure": "Pharmacokinetics of THC, CBD and metabolites",
                    "description": "Peak blood levels of THC, CBD, 11-OH-THC, and THCCOOH after exposure (Tmax)",
                    "timeFrame": "6 hours"
                },
                {
                    "measure": "Behavioral task performance as assessed by the DRUID App Score",
                    "description": "Trough composite scores on the DRUID App",
                    "timeFrame": "6 hour"
                },
                {
                    "measure": "THC concentrations in oral fluid",
                    "description": "Peak levels of THC in oral fluid after exposure",
                    "timeFrame": "6 hour"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or non-pregnant and non-lactating females aged 21-55 years\n* Report weekly-monthly use of cannabis (\u22641 day per week) over the past month prior to screening,\n* Not currently seeking treatment for their cannabis use\n* Have a Body Mass Index from 18.5 - 34kg/m2.\n* Able to perform all study procedures\n* Must be using a contraceptive (hormonal or barrier methods)\n\nExclusion Criteria:\n\n* Meeting DSM-V criteria for moderate to severe Cannabis Use disorder (CUD) or any substance use disorder other than nicotine, caffeine\n* Any other Axis I disorder\n* Report using other illicit drugs in the prior 4 weeks, other than cannabis.\n* Current use of any medications that may affect study outcomes\n* If medical history, physical and psychiatric examination, or laboratory tests performed during the screening process are not within the normal range and / or reveal any significant illness (e.g., hypertension) as judged by the study physician and to put the participant at greater risk of experiencing adverse events due to completion of study procedures.\n* Pregnancy is exclusionary due to the possible effects of the study medication on fetal development.\n* History of an allergic reaction or adverse reaction to cannabis is exclusionary.\n* History of respiratory illness or current respiratory illness\n* Currently enrolled in another research protocol\n* Not using a contraceptive method (hormonal or barrier methods)\n* The evaluating physician reviews all medical assessments along with medical history. Any disorders that might make cannabis administration hazardous are exclusionary.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "21 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ziva Cooper, PhD",
                    "role": "CONTACT",
                    "phone": "310-206-9942",
                    "email": "zcooper@mednet.ucla.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Ziva Cooper, PhD",
                    "affiliation": "University of California, Los Angeles",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California, Los Angeles",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ziva Cooper, PhD",
                            "role": "CONTACT",
                            "phone": "310-206-9942",
                            "email": "zcooper@mednet.ucla.edu"
                        },
                        {
                            "name": "Vincent Acebo, PhD",
                            "role": "CONTACT",
                            "phone": "310-983-3417",
                            "email": "vacebo@mednet.ucla.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                }
            ],
            "ancestors": [
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5449",
                    "name": "Marijuana Abuse",
                    "relevance": "LOW"
                },
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "asFound": "Drug Abuse",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000013759",
                    "term": "Dronabinol"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006213",
                    "term": "Hallucinogens"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                },
                {
                    "id": "D000018712",
                    "term": "Analgesics, Non-Narcotic"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000063386",
                    "term": "Cannabinoid Receptor Agonists"
                },
                {
                    "id": "D000063385",
                    "term": "Cannabinoid Receptor Modulators"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16527",
                    "name": "Dronabinol",
                    "asFound": "1500",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9305",
                    "name": "Hallucinogens",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20786",
                    "name": "Analgesics, Non-Narcotic",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}